$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx

$olpx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000186872624000010 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$98.91M	$111.7M	$458.3M
YoY Change	-13.08%	-14.54%	-34.93%
Cost Of Revenue	$27.56M	$34.94M	$139.7M
YoY Change	-16.42%	-9.56%	-24.39%
Gross Profit	$71.34M	$76.78M	$318.6M
YoY Change	-11.72%	-16.63%	-38.67%
Gross Profit Margin	72.13%	68.73%	69.52%
Selling, General & Admin	$40.44M	$49.17M	$168.9M
YoY Change	15.79%	41.93%	48.35%
% of Gross Profit	56.68%	64.04%	53.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$149.0K	$12.63M	$479.0K
YoY Change	28.45%	-2.37%	31.96%
% of Gross Profit	0.21%	16.44%	0.15%
Operating Expenses	$51.73M	$59.62M	$210.4M
YoY Change	14.32%	32.37%	35.61%
Operating Profit	$19.62M	$17.16M	$108.2M
YoY Change	-44.84%	-63.52%	-70.3%
Interest Expense	$14.50M	-$8.867M	$57.95M
YoY Change	37.57%	-15.75%	40.74%
% of Operating Profit	73.94%	-51.66%	53.55%
Other Income/Expense, Net	-$947.0K	$1.548M	$7.624M
YoY Change	-491.32%	-3.01%	-142.41%
Pretax Income	$10.37M	$17.25M	$76.72M
YoY Change	-58.95%	-58.14%	-74.87%
Income Tax	$2.623M	$3.147M	$15.13M
% Of Pretax Income	25.3%	18.25%	19.72%
Net Earnings	$7.746M	$14.10M	$61.59M
YoY Change	-63.05%	-58.07%	-74.77%
Net Earnings / Revenue	7.83%	12.62%	13.44%
Basic Earnings Per Share	$0.01		$0.09
Diluted Earnings Per Share	$0.01	$0.02	$0.09
COMMON SHARES
Basic Shares Outstanding	660.8M shares	654.7M shares	654.6M shares
Diluted Shares Outstanding	663.6M shares		677.6M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$507.5M	$466.4M	$466.4M
YoY Change	37.41%	44.48%	44.48%
Cash & Equivalents	$507.5M	$466.4M	$466.4M
Short-Term Investments
Other Short-Term Assets	$11.54M	$9.953M	$9.953M
YoY Change	-30.75%	13.48%	13.48%
Inventory	$94.64M	$95.92M	$95.92M
Prepaid Expenses
Receivables	$25.81M	$40.92M	$40.92M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$639.5M	$613.2M	$613.2M
YoY Change	13.48%	17.42%	17.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.241M	$930.0K	$930.0K
YoY Change	20.96%	-10.06%	-10.06%
Goodwill	$168.3M	$168.3M
YoY Change	0.0%	0.0%
Intangibles	$935.9M	$947.7M
YoY Change	-4.79%	-4.76%
Long-Term Investments	$8.416M
YoY Change
Other Assets	$8.416M	$10.20M	$10.20M
YoY Change	-15.87%	-8.03%
Total Long-Term Assets	$1.114B	$1.127B	$1.127B
YoY Change	-4.17%	-4.11%	-4.11%
TOTAL ASSETS
Total Short-Term Assets	$639.5M	$613.2M	$613.2M
Total Long-Term Assets	$1.114B	$1.127B	$1.127B
Total Assets	$1.753B	$1.740B	$1.740B
YoY Change	1.6%	2.51%	2.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.22M	$7.073M	$7.073M
YoY Change	83.06%	-27.44%	-27.44%
Accrued Expenses	$18.16M	$20.58M	$28.59M
YoY Change	-8.85%	20.28%	54.49%
Deferred Revenue	$1.067M	$1.051M
YoY Change	-52.15%	-47.84%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.750M	$6.750M	$6.750M
YoY Change	0.0%	-20.0%	-20.0%
Total Short-Term Liabilities	$59.73M	$56.14M	$56.14M
YoY Change	2.57%	1.91%	1.91%
LONG-TERM LIABILITIES
Long-Term Debt	$647.7M	$649.0M	$649.0M
YoY Change	-0.81%	-0.81%	-0.81%
Other Long-Term Liabilities	$2.065M	$1.694M	$187.2M
YoY Change	-99.0%	-99.18%	-8.99%
Total Long-Term Liabilities	$649.8M	$650.7M	$836.2M
YoY Change	-0.5%	-0.55%	-2.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.73M	$56.14M	$56.14M
Total Long-Term Liabilities	$649.8M	$650.7M	$836.2M
Total Liabilities	$897.7M	$895.4M	$895.4M
YoY Change	-2.34%	-2.33%	-2.33%
SHAREHOLDERS EQUITY
Retained Earnings	$534.2M	$526.4M
YoY Change	9.96%	13.25%
Common Stock	$675.0K	$671.0K
YoY Change	3.37%	3.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$855.7M	$845.0M	$845.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.753B	$1.740B	$1.740B
YoY Change	1.6%	2.51%	2.51%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$7.746M	$14.10M	$61.59M
YoY Change	-63.05%	-58.07%	-74.77%
Depreciation, Depletion And Amortization	$149.0K	$12.63M	$479.0K
YoY Change	28.45%	-2.37%	31.96%
Cash From Operating Activities	$43.71M	$49.04M	$177.5M
YoY Change	-9.11%	-33.3%	-30.47%
INVESTING ACTIVITIES
Capital Expenditures	$451.0K	$712.0K	$375.0K
YoY Change	321.5%	-26.6%	-42.31%
Acquisitions
YoY Change
Other Investing Activities	-$1.084M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$1.084M	-$712.0K	-$3.614M
YoY Change	71.79%	-26.6%	34.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.517M	-11.51M	-$30.33M
YoY Change	63.82%	-1435.15%	-73.91%
NET CHANGE
Cash From Operating Activities	$43.71M	49.04M	$177.5M
Cash From Investing Activities	-$1.084M	-712.0K	-$3.614M
Cash From Financing Activities	-$1.517M	-11.51M	-$30.33M
Net Change In Cash	$41.11M	36.81M	$143.6M
YoY Change	-11.66%	-49.85%	5.26%
FREE CASH FLOW
Cash From Operating Activities	$43.71M	$49.04M	$177.5M
Capital Expenditures	$451.0K	$712.0K	$375.0K
Free Cash Flow	$43.26M	$48.32M	$177.2M
YoY Change	-9.85%	-33.39%	-30.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Interest Expense InterestExpense	57954000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	654592923	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	649092846	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	691005846	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	689923792	shares
CY2021	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	844968000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244072000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5441000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34599000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	108222000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	364394000	usd
CY2022	us-gaap	Interest Expense InterestExpense	43953000	usd
CY2021	us-gaap	Interest Expense InterestExpense	61148000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	61587000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	58316000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001868726
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	olpx	Reorganization Conversion Ratio ReorganizationConversionRatio	0.00148
CY2021Q4	olpx	Reorganization Conversion Ratio ReorganizationConversionRatio	0.00148
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40860
CY2023	dei	Entity Registrant Name EntityRegistrantName	Olaplex Holdings, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1242679
CY2023	dei	City Area Code CityAreaCode	310
CY2023	dei	Local Phone Number LocalPhoneNumber	691-0776
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	OLPX
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	500000000	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	660757501	shares
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	466400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322808000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	21465000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19198000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40921000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46220000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	95922000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	144425000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9953000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8771000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	613196000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	522224000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	930000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1034000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	947714000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	995028000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10198000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11089000	usd
CY2023Q4	us-gaap	Assets Assets	1740338000	usd
CY2022Q4	us-gaap	Assets Assets	1697675000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7073000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9748000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9067000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3415000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20576000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17107000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6750000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8438000	usd
CY2023Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	12675000	usd
CY2022Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	16380000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56141000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	55088000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	649023000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	654333000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3016000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1622000	usd
CY2023Q4	olpx	Tax Receivable Agreement Noncurrent TaxReceivableAgreementNoncurrent	185496000	usd
CY2022Q4	olpx	Tax Receivable Agreement Noncurrent TaxReceivableAgreementNoncurrent	205675000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1694000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Liabilities	895370000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	916718000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	660731935	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	660731935	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	650091380	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	650091380	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	671000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	649000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	316489000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	312875000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1365000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2577000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	526443000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	464856000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	844968000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	780957000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1740338000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1697675000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	458300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	704274000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	598365000	usd
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	131323000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	177221000	usd
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	116554000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	7500000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	7989000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	124543000	usd
CY2023	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	41468000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	210410000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	155159000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	334154000	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	18828000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	2775000	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18803000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	olpx	Tax Receivable Agreement Liability Adjustment Operating Activities TaxReceivableAgreementLiabilityAdjustmentOperatingActivities	7404000	usd
CY2022	olpx	Tax Receivable Agreement Liability Adjustment Operating Activities TaxReceivableAgreementLiabilityAdjustmentOperatingActivities	3084000	usd
CY2021	olpx	Tax Receivable Agreement Liability Adjustment Operating Activities TaxReceivableAgreementLiabilityAdjustmentOperatingActivities	3615000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7624000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17975000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2603000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	275609000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	648166472	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	677578245	shares
CY2023	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-1212000	usd
CY2022	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	2577000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1212000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2577000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	60375000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	246649000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	220784000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	530673000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	633000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	220784000	usd
CY2021	olpx	Adjustments To Additional Paid In Capital Tax Receivable Agreement AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement	232893000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3963000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1138000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	524298000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244072000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1632000	usd
CY2022	olpx	Stock Issued During Period Value Non Option Equity Instruments Exercised StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised	638000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7275000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1877000	usd
CY2022	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	2577000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	780957000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	61587000	usd
CY2023	olpx	Stock Issued During Period Value Non Option Equity Instruments Exercised StockIssuedDuringPeriodValueNonOptionEquityInstrumentsExercised	326000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9072000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	18723000	usd
CY2023	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-1212000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	8345000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	7500000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	7989000	usd
CY2023	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	41468000	usd
CY2022	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	41282000	usd
CY2021	olpx	Amortization Of Other Intangible Assets AmortizationOfOtherIntangibleAssets	40790000	usd
CY2023	olpx	Inventory Write Down And Disposal InventoryWriteDownAndDisposal	15227000	usd
CY2022	olpx	Inventory Write Down And Disposal InventoryWriteDownAndDisposal	8180000	usd
CY2021	olpx	Inventory Write Down And Disposal InventoryWriteDownAndDisposal	0	usd
CY2023	us-gaap	Depreciation Depreciation	479000	usd
CY2022	us-gaap	Depreciation Depreciation	363000	usd
CY2021	us-gaap	Depreciation Depreciation	162000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1812000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1543000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2830000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1774000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9179000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2486000	usd
CY2023	olpx	Tax Receivable Agreement Liability Adjustment TaxReceivableAgreementLiabilityAdjustment	7404000	usd
CY2022	olpx	Tax Receivable Agreement Liability Adjustment TaxReceivableAgreementLiabilityAdjustment	3084000	usd
CY2021	olpx	Tax Receivable Agreement Liability Adjustment TaxReceivableAgreementLiabilityAdjustment	3615000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	9072000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7275000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3963000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18803000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1060000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-412000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5299000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	7199000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9419000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2352000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8722000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7322000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19613000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	467000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	6229000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	177532000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	255324000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	200029000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	375000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	650000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	875000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	500000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	2739000	usd
CY2022	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	2032000	usd
CY2021	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	890000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3614000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2682000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6265000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	633000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4974000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1876000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1138000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	8438000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	780380000	usd
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	20111000	usd
CY2023	olpx	Payment To Pre Ipo Stockholders Pursuant To Tax Receivable Agreement PaymentToPreIPOStockholdersPursuantToTaxReceivableAgreement	16452000	usd
CY2022	olpx	Payment To Pre Ipo Stockholders Pursuant To Tax Receivable Agreement PaymentToPreIPOStockholdersPursuantToTaxReceivableAgreement	0	usd
CY2021	olpx	Payment To Pre Ipo Stockholders Pursuant To Tax Receivable Agreement PaymentToPreIPOStockholdersPursuantToTaxReceivableAgreement	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	675000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11944000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30326000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-116222000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18340000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	143592000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	136420000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	322808000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186388000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	59922000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	33812000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	59595000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	41226000	usd
CY2023	olpx	Initial Public Offering And Strategic Transition Costs Included In Accounts Payable And Accrued Expenses InitialPublicOfferingAndStrategicTransitionCostsIncludedInAccountsPayableAndAccruedExpenses	0	usd
CY2022	olpx	Initial Public Offering And Strategic Transition Costs Included In Accounts Payable And Accrued Expenses InitialPublicOfferingAndStrategicTransitionCostsIncludedInAccountsPayableAndAccruedExpenses	0	usd
CY2021	olpx	Initial Public Offering And Strategic Transition Costs Included In Accounts Payable And Accrued Expenses InitialPublicOfferingAndStrategicTransitionCostsIncludedInAccountsPayableAndAccruedExpenses	243000	usd
CY2023	olpx	Transfer To Due To Related Parties TransferToDueToRelatedParties	0	usd
CY2022	olpx	Transfer To Due To Related Parties TransferToDueToRelatedParties	0	usd
CY2021	olpx	Transfer To Due To Related Parties TransferToDueToRelatedParties	232893000	usd
CY2023	olpx	Noncash Stock Options Exercised NoncashStockOptionsExercised	13749000	usd
CY2022	olpx	Noncash Stock Options Exercised NoncashStockOptionsExercised	0	usd
CY2021	olpx	Noncash Stock Options Exercised NoncashStockOptionsExercised	0	usd
CY2023	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	0	usd
CY2022	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	1632000	usd
CY2021	olpx	Liability Reclassification To Additional Paid In Capital LiabilityReclassificationToAdditionalPaidInCapital	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2128000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19198000	usd
CY2021Q4	olpx	Tax Receivable Agreement Percent Of Tax Benefits With Provided Payment TaxReceivableAgreementPercentOfTaxBenefitsWithProvidedPayment	0.85
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Estimates and Assumptions</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, variable consideration, and other obligations such as product returns, allowance for promotions, and refunds; loss contingencies; the fair value of share-based options and stock settled stock </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">appreciation rights (“SARs”); the fair value of and/or potential impairment of goodwill and intangible assets for the Company’s reporting unit; the fair value of the Company’s interest rate cap; useful lives of the Company’s tangible and intangible assets; estimated income tax expense and tax payments; future payment obligations under the Tax Receivable Agreement; the net realizable value of, and demand for the Company’s inventory. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.</span></div>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	466400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	322808000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	21465000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	15200000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2023	olpx	Number Of Operating Segment Components NumberOfOperatingSegmentComponents	3	component
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8589000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10402000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1051000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2015000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-69000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2025000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1027000	usd
CY2021	olpx	Stock Issuance Costs StockIssuanceCosts	8488000	usd
CY2023	olpx	Number Of Operating Segment Components NumberOfOperatingSegmentComponents	3	component
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	olpx	Contract With Customer Liability Returns ContractWithCustomerLiabilityReturns	9155000	usd
CY2022	olpx	Contract With Customer Liability Returns ContractWithCustomerLiabilityReturns	9983000	usd
CY2021	olpx	Contract With Customer Liability Returns ContractWithCustomerLiabilityReturns	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1051000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2015000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2015000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5022000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents. Although the Company deposits its cash with creditworthy financial institutions, its deposits, at times, may exceed federally insured limits. To date, the Company has not experienced any losses on it cash deposits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company extends credit to customers in certain industries which may be affected by changes in economic or other external conditions. A small amount of the Company’s customers have net sales exceeding 10% of total net sales. During the year ended </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, two customers represented 21% of the Company’s total net sales, in aggregate, and represented</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 20% of the Company’s total accounts receivable balance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the year ended December 31, 2022, one customer represented 16% of the Company’s total net sales and represented an immaterial amount of the total accounts receivable balance. During the year ended December 31, 2021, two customers represented 25% of the Company’s total net sales, in aggregate, and represented 11% of the Company’s total accounts receivable balance. The Company has not experienced material bad debt losses due to this concentration.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases its inventories for certain product categories from a small number of vendors. The Company’s largest vendor represented 32%, 49% and 59% of the Company’s inventory product purchases for the years ended </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 and 2021, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One vendor manufactures products that accounted for more than 61%, 77% and 75% of the Company’s net sales for the years ended </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 and 2021, respectively. The Company’s products are also primarily manufactured and fulfilled by companies located in Southern California.</span></div>
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	60543000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	24864000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	11137000	usd
CY2021Q4	olpx	Tax Receivable Agreement Percent Of Tax Benefits With Provided Payment TaxReceivableAgreementPercentOfTaxBenefitsWithProvidedPayment	0.85
CY2021Q4	olpx	Tax Receivable Agreement Percent Of Tax Benefits Retained By Company TaxReceivableAgreementPercentOfTaxBenefitsRetainedByCompany	0.15
CY2023Q4	olpx	Tax Receivable Agreement TaxReceivableAgreement	198200000	usd
CY2023	olpx	Related Party Transaction Term Of Agreement RelatedPartyTransactionTermOfAgreement	P12Y
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts presented have been reclassified within “Note 8 - Accrued Expenses and Other Current Liabilities” as of </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to conform with the current period presentation, including a prior year reclassification from Other accrued expenses and current liabilities to Accrued advertising. The reclassifications occurred as a result of an increase in the significance of the current year amount. There was no change to the Consolidated Balance Sheet, Statements of Operations and Comprehensive Income, and Statement of Cash Flows from the reclassification.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain amounts presented have been reclassified within the “Consolidated Statements of Operations and Comprehensive Income” to conform with the current period presentation, including a prior year reclassification from Interest expense, net to Interest income for years ending December 31, 2023, 2022 and 2021. The reclassifications occurred as a result of an increase in the significance of the current year amount. There was no change to the Consolidated Balance Sheet, Statements of Operations and Comprehensive Income, and Statement of Cash Flows from the reclassification.</span></div>
CY2023Q4	olpx	Number Of Business Channels NumberOfBusinessChannels	3	business_channel
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	458300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	704274000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	598365000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	458300000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	704274000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	598365000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30306000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36194000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	65616000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	108231000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	95922000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	144425000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	15200000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q4	olpx	Equity Securities Without Readily Determinable Fair Value Capital Contributions Net Of Distributions And Impairments EquitySecuritiesWithoutReadilyDeterminableFairValueCapitalContributionsNetOfDistributionsAndImpairments	4500000	usd
CY2022Q4	olpx	Equity Securities Without Readily Determinable Fair Value Capital Contributions Net Of Distributions And Impairments EquitySecuritiesWithoutReadilyDeterminableFairValueCapitalContributionsNetOfDistributionsAndImpairments	4500000	usd
CY2023Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	4500000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	4500000	usd
CY2023	olpx	Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag	Interest rate cap at December 31, 2023
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1147160000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	199446000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	947714000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2023Q4	olpx	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	1315460000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	199446000	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1116014000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1143922000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148894000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	995028000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	168300000	usd
CY2022Q4	olpx	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	1312222000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	148894000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1163328000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20576000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17107000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	52274000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	51168000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50359000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	49833000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	49830000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	694250000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	947714000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4133000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3187000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4639000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4092000	usd
CY2023Q4	olpx	Accrued Freight Current AccruedFreightCurrent	1229000	usd
CY2022Q4	olpx	Accrued Freight Current AccruedFreightCurrent	3283000	usd
CY2023Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	6348000	usd
CY2022Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	1356000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1051000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2015000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	431000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	814000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2745000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2360000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7415000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8854000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	655773000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	662771000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6750000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8438000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	649023000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	654333000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	39126000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	41178000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	61148000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	655800000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	615100000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	662800000	usd
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	624600000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	76580000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	305192000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	275554000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	140000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	49000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	55000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	76720000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	305241000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	275609000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	150000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	424000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4264000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3488000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2249000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1273000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3297000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	usd
CY2023Q4	olpx	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	473000	usd
CY2022Q4	olpx	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2307000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	10701000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	44063000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	44660000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2618000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7918000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	7668000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	40000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	11000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13359000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	51990000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	52339000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1395000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	8172000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2772000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	379000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1007000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-286000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1774000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9179000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2486000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15133000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	61169000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	54825000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4248000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1289000	usd
CY2023Q4	olpx	Deferred Tax Assets Capitalized Transaction Costs DeferredTaxAssetsCapitalizedTransactionCosts	2301000	usd
CY2022Q4	olpx	Deferred Tax Assets Capitalized Transaction Costs DeferredTaxAssetsCapitalizedTransactionCosts	2667000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1380000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	176000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19465000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	10521000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	10128000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2484000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	9128000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	6962000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1175000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1141000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1169000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	769000	usd
CY2023Q4	olpx	Deferred Tax Liability Right Of Use Assets DeferredTaxLiabilityRightOfUseAssets	473000	usd
CY2022Q4	olpx	Deferred Tax Liability Right Of Use Assets DeferredTaxLiabilityRightOfUseAssets	0	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	408000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	787000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	22481000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	12143000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3016000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1622000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.039
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.029
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.030
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.026
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.004
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.012
CY2023	olpx	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Percent EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementPercent	-0.020
CY2022	olpx	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Percent EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementPercent	-0.002
CY2021	olpx	Effective Income Tax Rate Reconciliation Tax Receivable Agreement Percent EffectiveIncomeTaxRateReconciliationTaxReceivableAgreementPercent	-0.003
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.197
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.200
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.199
CY2023	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	16600000	usd
CY2022	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	4200000	usd
CY2023Q4	olpx	Tax Receivable Agreement TaxReceivableAgreement	198200000	usd
CY2023	olpx	Related Party Transaction Term Of Agreement RelatedPartyTransactionTermOfAgreement	P12Y
CY2021Q3	olpx	Tax Receivable Agreement TaxReceivableAgreement	232900000	usd
CY2023Q4	us-gaap	Other Income OtherIncome	7400000	usd
CY2022Q4	us-gaap	Other Income OtherIncome	3100000	usd
CY2021Q4	us-gaap	Other Income OtherIncome	3600000	usd
CY2023Q4	olpx	Tax Receivable Agreement TaxReceivableAgreement	198200000	usd
CY2023Q4	olpx	Tax Receivable Agreement Noncurrent TaxReceivableAgreementNoncurrent	185500000	usd
CY2023Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	12700000	usd
CY2022Q4	olpx	Tax Receivable Agreement TaxReceivableAgreement	222100000	usd
CY2022Q4	olpx	Tax Receivable Agreement Noncurrent TaxReceivableAgreementNoncurrent	205700000	usd
CY2022Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	16400000	usd
CY2022Q1	olpx	Base Share Price BaseSharePrice	2.97
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15786501	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	14736290	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9072000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7275000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3963000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	13015000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	17968000	usd
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	11638000	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	23396654	shares
CY2023	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	12782218	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1189681	shares
CY2023	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	16600000	usd
CY2022	olpx	Payments For Tax Receivable Agreement PaymentsForTaxReceivableAgreement	4200000	usd
CY2023	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	CONTINGENCIES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is subject to various legal actions arising in the ordinary course of business. The Company cannot predict with reasonable assurance the outcome of these legal actions brought against the Company as they are subject to uncertainties. Accordingly, any settlement or resolution in these legal actions may occur and affect the Company’s net income in such period as the settlement or resolution.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending Legal Proceedings: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 17, 2022, a putative securities class action was filed against the Company and certain of its current and former officers and directors in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien v. Olaplex Holdings, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 2:22-cv-08395. A consolidated complaint was filed on April 28, 2023, which names as additional defendants the underwriters for the Company’s IPO and various stockholders that sold shares of common stock of the Company in the IPO. The action is brought on behalf of a putative class of purchasers of the Company’s common stock in or traceable to the Company’s IPO and asserts claims under Sections 11, 12, and 15 of the Securities Act of 1933. The action seeks certification of the putative class, compensatory damages, attorneys’ fees and costs, and any other relief that the court determines is appropriate. The defendants moved to dismiss the consolidated complaint on July 19, 2023. The court held a hearing on the defendants’ motions to dismiss on October 16, 2023, and a decision has yet to be issued. The underwriter defendants have notified the Company of their intent to seek indemnification from the Company pursuant to the IPO underwriting agreement regarding the claims asserted in this action. The Company intends to vigorously defend the pending lawsuit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2023, a purported derivative action was filed against the Company, Advent International Corporation, and certain of the Company’s current and former officers and directors in the United States District Court for the Central District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ciuffo v. Dagousset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, et al., No. 2:23-cv-09712-SVW-SK. This action is premised on allegations similar to those asserted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> federal securities litigation. On February 1, 2024, the parties filed a joint stipulation to stay the purported derivative action pending a decision on the motions to dismiss filed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lilien </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal securities action. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2023, twenty-eight plaintiffs filed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Albahae, et al. v. Olaplex Holdings, Inc., et al.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No. 2:23-cv-00982, a complaint alleging personal and economic injury and asserting claims for breach of warranty, negligence/gross negligence, products liability, unjust enrichment, and violations of California False Advertising Law and Unfair Competition Law, against the Company and Cosway Company, Inc., the Company’s primary contract manufacturer, in the United States District Court for the Central District of California. On March 2, 2023, the plaintiffs amended the complaint to include seventy-three additional plaintiffs. The plaintiffs allege that certain ingredients used in some Company products have purportedly caused irritation or posed a hazard to consumers, and that the Company engaged in misrepresentation with respect to those products. The plaintiffs seek actual and consequential damages, punitive damages, restitution in the form of disgorgement of profits, attorneys’ fees and costs, and any other relief that the court determines is appropriate. On April 17, 2023, the Company moved to dismiss and to sever the plaintiffs’ claims. On July 11, 2023, the Court granted the Company’s motion to sever and dismissed all but the first named plaintiff. The Court also dismissed the operative complaint with leave to re-file on the grounds that it now contained allegations that were not relevant to the claims of the one, remaining plaintiff. On July 24, 2023, the remaining plaintiff filed a notice, voluntarily dismissing her claims without prejudice. As of the date of issuance of these consolidated financial statements, none of the plaintiffs have re-filed their claims. </span></div><div style="margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any potential loss associated with these pending legal proceedings is not probable or reasonably estimable at this time.</span></div>As of December 31, 2023 and December 31, 2022, the Company was not subject to any other currently pending legal matters or claims that could have a material adverse effect on its financial position, results of operations, or cash flows should such litigation be resolved unfavorably. During the year ended December 31, 2021, the Company expensed approximately $14,250 included in selling, general and administrative costs in the accompanying consolidated financial statements associated with the amounts paid by the Company in connection with the final resolution of certain litigation and contingency matters involving a predecessor entity to the Company, as required pursuant to the purchase agreement with respect to the 2020 acquisition of the legacy Olaplex business.
CY2023Q1	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	28	plaintiff
CY2023Q1	us-gaap	Loss Contingency Number Of Plaintiffs LossContingencyNumberOfPlaintiffs	73	plaintiff
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	14250000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	61587000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244072000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	220784000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	654592923	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	649092846	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	648166472	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	22985322	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	41913000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	41757320	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	677578245	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	691005846	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	689923792	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4372562	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1194967	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	660731935	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	660731935	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	650091380	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	650091380	shares
CY2023Q4	olpx	Tax Receivable Agreement TaxReceivableAgreement	198200000	usd
CY2022Q4	olpx	Tax Receivable Agreement TaxReceivableAgreement	222100000	usd
CY2023Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	12700000	usd
CY2022Q4	olpx	Tax Receivable Agreement Current TaxReceivableAgreementCurrent	16400000	usd

Files In Submission

Name	View Source	Status
0001868726-24-000010-index-headers.html	Edgar Link	pending
0001868726-24-000010-index.html	Edgar Link	pending
0001868726-24-000010.txt	Edgar Link	pending
0001868726-24-000010-xbrl.zip	Edgar Link	pending
ex1018transitionseparation.htm	Edgar Link	pending
ex1019amendedrestatedoffer.htm	Edgar Link	pending
ex211subsidiariesoftheregi.htm	Edgar Link	pending
ex231consentofdeloittetouc.htm	Edgar Link	pending
ex311-q42023ceocertificati.htm	Edgar Link	pending
ex312-q423cfocertificate.htm	Edgar Link	pending
ex321-q423ceocertificate.htm	Edgar Link	pending
ex322-q423cfocertificate.htm	Edgar Link	pending
ex97policyforrecoupmentofi.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
olpx-20231231.htm	Edgar Link	pending
olpx-20231231.xsd	Edgar Link	pending
olpx-20231231_g1.jpg	Edgar Link	pending
olpx-20231231_g2.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
olpx-20231231_cal.xml	Edgar Link	unprocessable
olpx-20231231_def.xml	Edgar Link	unprocessable
olpx-20231231_lab.xml	Edgar Link	unprocessable
olpx-20231231_pre.xml	Edgar Link	unprocessable
olpx-20231231_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx

2024 Q1 Form 10-K Financial Statement

#000186872624000010 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLPX OLAPLEX HOLDINGS, INC. Stock $olpx

2024 Q1 Form 10-K Financial Statement

#000186872624000010 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OLPX
OLAPLEX HOLDINGS, INC. Stock $olpx